Reyon Pharmaceutical Co Ltd (102460) — Free Cash Flow Generation Index
Reyon Pharmaceutical Co Ltd (102460) has a Free Cash Flow Generation Index of -0.76x as of March 2025. Free cash flow of ₩-1.83 Billion represents -1% of operating cash flow (₩2.41 Billion). See 102460 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Reyon Pharmaceutical Co Ltd Free Cash Flow Generation Index (2008–2023)
Historical FCF Generation Index trend for Reyon Pharmaceutical Co Ltd across 11 annual periods. Explore Reyon Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Reyon Pharmaceutical Co Ltd (2008–2023)
Year-by-year Free Cash Flow Generation Index for Reyon Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Reyon Pharmaceutical Co Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -2.34x | ₩-20.23 Billion | ₩8.65 Billion | ₩28.87 Billion | ▲ +62.5% |
| 2022 | -6.23x | ₩-54.40 Billion | ₩8.73 Billion | ₩63.13 Billion | ▲ +30.9% |
| 2021 | -9.01x | ₩-105.31 Billion | ₩11.68 Billion | ₩116.98 Billion | ▲ +13.1% |
| 2020 | -10.37x | ₩-47.71 Billion | ₩4.60 Billion | ₩52.31 Billion | ▼ -324.7% |
| 2018 | -2.44x | ₩-27.97 Billion | ₩11.45 Billion | ₩39.17 Billion | ▼ -439.1% |
| 2017 | 0.72x | ₩12.08 Billion | ₩16.76 Billion | ₩4.14 Billion | ▼ -46.2% |
| 2016 | 1.34x | ₩12.68 Billion | ₩9.47 Billion | ₩3.21 Billion | ▲ +22.0% |
| 2012 | 1.10x | ₩27.07 Billion | ₩24.65 Billion | ₩2.42 Billion | ▼ -5.1% |
| 2011 | 1.16x | ₩17.76 Billion | ₩15.34 Billion | ₩2.42 Billion | ▼ -0.9% |
| 2009 | 1.17x | ₩10.14 Billion | ₩8.68 Billion | ₩1.46 Billion | ▼ -13.1% |
| 2008 | 1.34x | ₩8.04 Billion | ₩5.99 Billion | ₩2.06 Billion | — |